LAVA Therapeutics N.V. (LVTX) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

LAVA Therapeutics N.V. (LVTX) quarterly balance sheet — complete assets, liabilities & equity history

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22

Total Current Assets	51.91M	60.49M	69.78M	79.3M	81.54M	90.17M	96.67M	98.9M	107.92M	118.52M	130.61M	140.53M
Cash & Short-Term Investments	49.66M	56.17M	66.56M	76.58M	78.88M	86.8M	94.57M	95.57M	104.63M	112.4M	125.43M	132.87M
Cash Only	49.66M	26.38M	39.67M	35.02M	26.96M	35.09M	43.19M	44.23M	62.66M	87.61M	100.6M	100.33M
Short-Term Investments	0	29.79M	26.88M	41.56M	51.92M	51.71M	51.39M	51.34M	41.96M	24.8M	24.83M	32.53M
Accounts Receivable	0	0	0	0	1.02M	1.15M	907K	1.7M	1.38M	3.99M	2.02M	3.25M
Days Sales Outstanding	-	-	-	-	-	-	47.35	1.76K	9.53K	283.68	602.37	449.89
Inventory	0	0	0	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-	-	-
Other Current Assets	2.1M	2.4M	1.66M	1.65M	0	2.22M	1.19M	0	1.91M	383K	3.16M	4.41M
Total Non-Current Assets	10K	52K	1.38M	1.53M	1.82M	2.11M	2.41M	2.78M	3.1M	4.02M	4.67M	2.89M
Property, Plant & Equipment	0	43K	1.28M	1.44M	1.71M	1.97M	2.15M	2.46M	2.78M	3.68M	3.69M	2.08M
Fixed Asset Turnover	-	-	-	3.46x	-	-	3.24x	0.14x	0.02x	1.40x	0.33x	1.27x
Goodwill	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	10K	9K	95K	91K	114K	144K	256K	319K	326K	346K	982K	809K
Total Assets	51.91M	60.55M	71.16M	80.83M	83.36M	92.28M	99.08M	101.67M	111.02M	122.54M	135.28M	143.43M
Asset Turnover	-	-	-	0.06x	-	-	0.07x	0.00x	0.00x	0.04x	0.01x	0.02x
Asset Growth %	-37.72%	-34.39%	-28.18%	-20.5%	-24.92%	-24.69%	-26.76%	-29.11%	-25.93%	6.27%	4.46%	3%
Total Current Liabilities	4.23M	5.61M	10.37M	18.01M	15.2M	14.11M	13.03M	14.89M	20.75M	22.33M	23.57M	21.95M
Accounts Payable	1.7M	1.43M	1.52M	2.72M	2.81M	4.16M	3.44M	4.45M	9.38M	5.07M	3.12M	3.96M
Days Payables Outstanding	-	-	-	40.47	-	-	-	10.54K	342.52K	774.48	1.22K	-
Short-Term Debt	0	0	0	4.89M	5.76M	5.38M	5.29M	5.28M	4.94M	4.95M	4.85M	4.64M
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	0	2.19M	2.49M	949K	0	0	0	460K	0	1.4M	4.83M	5.14M
Current Ratio	12.27x	10.78x	6.73x	4.40x	5.36x	6.39x	7.42x	6.64x	5.20x	5.31x	5.54x	6.40x
Quick Ratio	12.27x	10.78x	6.73x	4.40x	5.36x	6.39x	7.42x	6.64x	5.20x	5.31x	5.54x	6.40x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	35M	35M	35.01M	35.08M	35.16M	35.3M	35.39M	35.41M	35.67M	36.32M	36.43M	35.43M
Long-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	6K	80K	164K	295K	387K	415K	671K	1.32M	1.43M	431K
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	35M	0	0	0	0	0	0	0	0	35M	0	0
Total Liabilities	39.23M	40.61M	45.37M	53.09M	50.36M	49.41M	48.41M	50.31M	56.42M	58.65M	60.01M	57.38M
Total Debt	0	0	312K	5.28M	6.29M	6.16M	6.13M	6.11M	6.2M	6.95M	6.98M	5.45M
Net Debt	-49.66M	-26.38M	-39.36M	-29.73M	-20.67M	-28.92M	-37.05M	-38.12M	-56.47M	-80.66M	-93.62M	-94.88M
Debt / Equity	-	-	0.01x	0.19x	0.19x	0.14x	0.12x	0.12x	0.11x	0.11x	0.09x	0.06x
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-	-	-58.82x	-13.78x	-	-	-	-	-	-	-	-
Total Equity	12.68M	19.93M	25.78M	27.75M	32.99M	42.88M	50.66M	51.36M	54.6M	63.89M	75.28M	86.04M
Equity Growth %	-61.56%	-53.51%	-49.11%	-45.98%	-39.57%	-32.89%	-32.69%	-40.3%	-41.08%	-32.06%	-30.56%	-27.31%
Book Value per Share	0.47	0.74	0.96	1.03	1.23	1.60	1.89	1.92	2.08	2.43	2.86	3.27
Total Shareholders' Equity	12.68M	19.93M	25.78M	27.75M	32.99M	42.88M	50.66M	51.36M	54.6M	63.89M	75.28M	86.04M
Common Stock	3.72M	3.72M	3.72M	3.72M	3.72M	3.72M	3.71M	3.71M	3.71M	3.71M	3.71M	3.71M
Retained Earnings	-194.28M	-187.09M	-178.45M	-174.97M	-168.93M	-156.72M	-148.48M	-149.86M	-141.91M	-134.71M	-122.01M	-108.07M
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-9.78M	-9.33M	-11.68M	-12.65M	-10.6M	-12.29M	-11.96M	-10.9M	-13.05M	463K	-11.43M	-12.97M
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0

LAVA Therapeutics N.V. (LVTX) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

LAVA Therapeutics N.V. (LVTX) quarterly balance sheet — complete assets, liabilities & equity history

Annual Quarterly

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22

Total Current Assets	51.91M	60.49M	69.78M	79.3M	81.54M	90.17M	96.67M	98.9M	107.92M	118.52M	130.61M	140.53M
Cash & Short-Term Investments	49.66M	56.17M	66.56M	76.58M	78.88M	86.8M	94.57M	95.57M	104.63M	112.4M	125.43M	132.87M
Cash Only	49.66M	26.38M	39.67M	35.02M	26.96M	35.09M	43.19M	44.23M	62.66M	87.61M	100.6M	100.33M
Short-Term Investments	0	29.79M	26.88M	41.56M	51.92M	51.71M	51.39M	51.34M	41.96M	24.8M	24.83M	32.53M
Accounts Receivable	0	0	0	0	1.02M	1.15M	907K	1.7M	1.38M	3.99M	2.02M	3.25M
Days Sales Outstanding	-	-	-	-	-	-	47.35	1.76K	9.53K	283.68	602.37	449.89
Inventory	0	0	0	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-	-	-
Other Current Assets	2.1M	2.4M	1.66M	1.65M	0	2.22M	1.19M	0	1.91M	383K	3.16M	4.41M
Total Non-Current Assets	10K	52K	1.38M	1.53M	1.82M	2.11M	2.41M	2.78M	3.1M	4.02M	4.67M	2.89M
Property, Plant & Equipment	0	43K	1.28M	1.44M	1.71M	1.97M	2.15M	2.46M	2.78M	3.68M	3.69M	2.08M
Fixed Asset Turnover	-	-	-	3.46x	-	-	3.24x	0.14x	0.02x	1.40x	0.33x	1.27x
Goodwill	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	10K	9K	95K	91K	114K	144K	256K	319K	326K	346K	982K	809K
Total Assets	51.91M	60.55M	71.16M	80.83M	83.36M	92.28M	99.08M	101.67M	111.02M	122.54M	135.28M	143.43M
Asset Turnover	-	-	-	0.06x	-	-	0.07x	0.00x	0.00x	0.04x	0.01x	0.02x
Asset Growth %	-37.72%	-34.39%	-28.18%	-20.5%	-24.92%	-24.69%	-26.76%	-29.11%	-25.93%	6.27%	4.46%	3%
Total Current Liabilities	4.23M	5.61M	10.37M	18.01M	15.2M	14.11M	13.03M	14.89M	20.75M	22.33M	23.57M	21.95M
Accounts Payable	1.7M	1.43M	1.52M	2.72M	2.81M	4.16M	3.44M	4.45M	9.38M	5.07M	3.12M	3.96M
Days Payables Outstanding	-	-	-	40.47	-	-	-	10.54K	342.52K	774.48	1.22K	-
Short-Term Debt	0	0	0	4.89M	5.76M	5.38M	5.29M	5.28M	4.94M	4.95M	4.85M	4.64M
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	0	2.19M	2.49M	949K	0	0	0	460K	0	1.4M	4.83M	5.14M
Current Ratio	12.27x	10.78x	6.73x	4.40x	5.36x	6.39x	7.42x	6.64x	5.20x	5.31x	5.54x	6.40x
Quick Ratio	12.27x	10.78x	6.73x	4.40x	5.36x	6.39x	7.42x	6.64x	5.20x	5.31x	5.54x	6.40x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	35M	35M	35.01M	35.08M	35.16M	35.3M	35.39M	35.41M	35.67M	36.32M	36.43M	35.43M
Long-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	6K	80K	164K	295K	387K	415K	671K	1.32M	1.43M	431K
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	35M	0	0	0	0	0	0	0	0	35M	0	0
Total Liabilities	39.23M	40.61M	45.37M	53.09M	50.36M	49.41M	48.41M	50.31M	56.42M	58.65M	60.01M	57.38M
Total Debt	0	0	312K	5.28M	6.29M	6.16M	6.13M	6.11M	6.2M	6.95M	6.98M	5.45M
Net Debt	-49.66M	-26.38M	-39.36M	-29.73M	-20.67M	-28.92M	-37.05M	-38.12M	-56.47M	-80.66M	-93.62M	-94.88M
Debt / Equity	-	-	0.01x	0.19x	0.19x	0.14x	0.12x	0.12x	0.11x	0.11x	0.09x	0.06x
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-	-	-58.82x	-13.78x	-	-	-	-	-	-	-	-
Total Equity	12.68M	19.93M	25.78M	27.75M	32.99M	42.88M	50.66M	51.36M	54.6M	63.89M	75.28M	86.04M
Equity Growth %	-61.56%	-53.51%	-49.11%	-45.98%	-39.57%	-32.89%	-32.69%	-40.3%	-41.08%	-32.06%	-30.56%	-27.31%
Book Value per Share	0.47	0.74	0.96	1.03	1.23	1.60	1.89	1.92	2.08	2.43	2.86	3.27
Total Shareholders' Equity	12.68M	19.93M	25.78M	27.75M	32.99M	42.88M	50.66M	51.36M	54.6M	63.89M	75.28M	86.04M
Common Stock	3.72M	3.72M	3.72M	3.72M	3.72M	3.72M	3.71M	3.71M	3.71M	3.71M	3.71M	3.71M
Retained Earnings	-194.28M	-187.09M	-178.45M	-174.97M	-168.93M	-156.72M	-148.48M	-149.86M	-141.91M	-134.71M	-122.01M	-108.07M
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-9.78M	-9.33M	-11.68M	-12.65M	-10.6M	-12.29M	-11.96M	-10.9M	-13.05M	463K	-11.43M	-12.97M
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0

LVTX Balance Sheet

LVTX Balance Sheet